Safety and tolerability of AAV8 delivery of a broadly neutralizing antibody in adults living with HIV: a phase 1, dose-escalation trialJoseph P. Casazza, Maria Claudia Burgos Florez, Anita Arthur et al.|Nature Medicine|2022Cited by 94